The highly specialized nature of the Preclinical CRO Market Regulatory Landscape is a critical determinant of market dynamics, acting as both a barrier to entry for new players and a major driver of outsourcing demand. The core of this landscape revolves around adherence to Good Laboratory Practice (GLP) regulations, mandated by major bodies like the U.S. FDA, European Medicines Agency (EMA),...